SODIUM 1-((4-(3-(4-CHLOROPHENYL)-4,5-DIHYDRO-1H-PYRAZOL-1-YL)PHENYL)SULFONYL)-2-METHYLPROPANE-2-SULFONATE
UNII KA9EHF36PB
Substance Identification & Data
This profile provides standardized clinical and technical data for Sodium 1-((4-(3-(4-chlorophenyl)-4,5-dihydro-1h-pyrazol-1-yl)phenyl)sulfonyl)-2-methylpropane-2-sulfonate, uniquely identified by the FDA Unique Ingredient Identifier (UNII) KA9EHF36PB.
Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 58370-37-9 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.
Detailed Substance Profile
C19H20ClN2O5S2.Na ABPKZRFIDANJLM-UHFFFAOYSA-M Synonyms and Nomenclature
This section provides a complete list of nomenclature and identifier mappings for Sodium 1-((4-(3-(4-chlorophenyl)-4,5-dihydro-1h-pyrazol-1-yl)phenyl)sulfonyl)-2-methylpropane-2-sulfonate. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.